Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Chase Therapeutics revenue
Chase Therapeutics's revenue is $15.0 million.
What is Chase Therapeutics's revenue?
- Chase Therapeutics has 175 employees, and the revenue per employee ratio is $85,714.
- Chase Therapeutics peak revenue was $15.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Chase Therapeutics financing
Chase Therapeutics received early financing of $1.3M on 2017-11-21.
| Series | Round size | Date |
|---|---|---|
| Series A | $1.3M | 11/2017 |
| Series A | $4M | 08/2018 |
| Series B | $20M | 10/2021 |
Chase Therapeutics investors
| Investors | Security type |
|---|---|
| China Link Capital | Series B |
Chase Therapeutics competitors
Chase Therapeutics's top competitor, XORTX Therapeutics, earned an annual revenue of $6.2B.
Chase Therapeutics's smallest competitor is Checkpoint Therapeutics with revenue of $41.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| XORTX Therapeutics | - | $6.2B | 2 | - |
| Seelos Therapeutics | - | $375,000 | 10 | - |
| Eikonizo Therapeutics | - | $250,000 | 9 | - |
| Checkpoint Therapeutics | - | $41,000 | 7 | - |
| Oncternal Therapeutics | - | $785,000 | 13 | - |
| Axial Therapeutics | - | $350,000 | 30 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Chase Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Chase Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Chase Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Chase Therapeutics. The data presented on this page does not represent the view of Chase Therapeutics and its employees or that of Zippia.
Chase Therapeutics may also be known as or be related to Chase Therapeutics.